Related references
Note: Only part of the references are listed.Cardiovascular biomarkers in patients with COVID-19
Christian Mueller et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)
High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19
Andrew R. Chapman et al.
CIRCULATION (2020)
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019
Shaobo Shi et al.
EUROPEAN HEART JOURNAL (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection
Anuradha Lala et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019
Shaobo Shi et al.
EUROPEAN HEART JOURNAL (2020)
Cardiac Troponin T and Troponin I in the General Population Comparing and Contrasting Their Genetic Determinants and Associations With Outcomes
Paul Welsh et al.
CIRCULATION (2019)
Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome
Kuan Ken Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Prevalence, Determinants, and Clinical Associations of High-Sensitivity Cardiac Troponin in Patients Attending Emergency Departments
Kuan Ken Lee et al.
AMERICAN JOURNAL OF MEDICINE (2019)
High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study
Anoop S. V. Shah et al.
LANCET (2015)
Share Paper
